GSK Profit Margin 2010-2022 | GSK
Current and historical gross margin, operating margin and net profit margin for GSK (GSK) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. GSK net profit margin as of September 30, 2022 is 37.88%.
| GSK Annual Profit Margins |
|---|
| GSK Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Biomedical and Genetics | $72.345B | $46.910B |
| GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bristol Myers Squibb (BMY) | United States | $155.188B | 9.47 |
| Bio-Rad Laboratories (BIO.B) | United States | $12.069B | 28.64 |
| QIAGEN (QGEN) | Netherlands | $11.333B | 19.34 |
| Ginkgo Bioworks Holdings (DNA) | United States | $3.395B | 0.00 |
| Myovant Sciences (MYOV) | United Kingdom | $2.604B | 0.00 |
| Arcus Biosciences (RCUS) | United States | $1.672B | 25.10 |
| Biohaven (BHVN) | United States | $1.264B | 0.00 |
| Emergent Biosolutions (EBS) | United States | $0.655B | 5.15 |
| ADC Therapeutics SA (ADCT) | Switzerland | $0.363B | 0.00 |
| Ambrx Biopharma (AMAM) | United States | $0.073B | 0.00 |
| Enzo Biochem (ENZ) | United States | $0.073B | 0.00 |
| Gelesis Holdings (GLS) | United States | $0.027B | 0.00 |
| SQZ Biotechnologies (SQZ) | United States | $0.025B | 0.00 |
